Rigel Pharmaceuticals (RIGL)
(Real Time Quote from BATS)
$1.08 USD
-0.02 (-1.82%)
Updated Apr 26, 2024 11:28 AM ET
3-Hold of 5 3
C Value F Growth A Momentum D VGM
Cash flow Statements
Fiscal Year End for Rigel Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -25.09 | -58.57 | -17.91 | -29.74 | -66.89 |
Depreciation/Amortization & Depletion | 0.76 | 0.94 | 1.45 | 0.58 | -0.39 |
Net Change from Assets/Liabilities | 9.52 | -29.05 | 9.72 | -30.32 | 16.66 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 9.07 | 12.93 | 12.63 | 7.30 | 9.12 |
Net Cash From Operating Activities | -5.74 | -73.76 | 5.88 | -52.19 | -41.51 |
Property & Equipment | 0.26 | 0.44 | -0.63 | -1.26 | -1.46 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 10.44 | 72.33 | -79.41 | 48.73 | -22.20 |
Other Investing Activities | -15.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -4.30 | 72.78 | -80.04 | 47.47 | -23.66 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.05 | 2.12 | 4.78 | 2.60 | 1.58 |
Issuance (Repayment) of Debt | 19.95 | 19.54 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.63 | -15.12 | 57.90 | 9.98 | 9.79 |
Net Cash from Financing Activities | 18.37 | 6.55 | 62.68 | 12.57 | 11.37 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | 8.33 | 5.57 | -11.48 | 7.85 | -53.80 |
Cash at Beginning of Period | 24.46 | 18.89 | 30.37 | 22.52 | 76.32 |
Cash at End of Period | 32.79 | 24.46 | 18.89 | 30.37 | 22.52 |
Diluted Net EPS | -0.14 | -0.34 | -0.11 | -0.18 | -0.40 |
Fiscal Year End for Rigel Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -25.09 | -25.83 | -20.14 | -13.54 |
Depreciation/Amortization & Depletion | NA | 0.76 | 0.73 | 0.54 | 0.29 |
Net Change from Assets/Liabilities | NA | 9.52 | 18.35 | 16.13 | 6.07 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 9.07 | 7.25 | 5.33 | 3.11 |
Net Cash From Operating Activities | NA | -5.74 | 0.50 | 1.86 | -4.07 |
Property & Equipment | NA | 0.26 | 0.15 | 0.13 | 0.13 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 10.44 | 17.43 | 18.62 | 15.65 |
Other Investing Activities | NA | -15.00 | -15.00 | -15.00 | -15.00 |
Net Cash from Investing Activities | NA | -4.30 | 2.58 | 3.75 | 0.78 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 1.05 | 0.56 | 0.55 | 0.00 |
Issuance (Repayment) of Debt | NA | 19.95 | 19.95 | 19.95 | 19.95 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | -2.63 | -2.63 | -1.75 | -0.83 |
Net Cash from Financing Activities | NA | 18.37 | 17.88 | 18.75 | 19.12 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | 8.33 | 20.96 | 24.35 | 15.83 |
Cash at Beginning of Period | NA | 24.46 | 24.46 | 24.46 | 24.46 |
Cash at End of Period | NA | 32.79 | 45.41 | 48.81 | 40.29 |
Diluted Net EPS | NA | 0.01 | -0.03 | -0.04 | -0.08 |